Skip to content

Analysis of the evolution of patients with Chronic Cervicalgia as a function of the Treatment of Choice.

Analysis of the clinical evolution of the Patient with Non-specific Chronic Neck Pain as a Choice of Treatment Choice. A randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2vj7sw
Enrollment
Unknown
Registered
2019-01-02
Start date
2019-01-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicalgia

Interventions

Protocol "Manual Therapy": (n=22) composed of three techniques based on scientific evidence. 1. High Thoracic Manipulation on T4 21 22 2. Cervical Articular Mobilization (2 Hz, 2 minutes x 3 series) 9
Other
E02.760.169.063.500.387
H02.010.625
HP3.073.433.101

Sponsors

Universidad de Sevilla
Lead Sponsor
Universidad de Sevilla
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Current neck pain. Neck pain continued for at least the last twelve weeks.

Exclusion criteria

Exclusion criteria: Irradiated neck pain. Neck pain associated with dizziness. Osteoporosis. Psychological disorders. Vertebral fractures Tumors Metabolic diseases. Previous neck surgery Red Flags (Night pain, severe muscle spasm, loss of involuntary weight, symptom mismatch). Physiotherapeutic treatment continued in the last three months.

Design outcomes

Primary

MeasureTime frame
Cervical Disability Index (IDC). The IDC is a self-assessment instrument of the specific functional status of subjects with neck pain with 10 elements that include pain, personal care, weight gain, reading, headache, concentration, work, driving, sleeping, and leisure. Each section is rated on a scale of 0 to 5, where 0 means "painless" and 5 means "the worst pain imaginable." The points obtained are added to a total score. The questionnaire was interpreted as a percentage. The disability categories for IDC are 0% -8%, without disability; 10% -28%, mild; 30% -48%, moderate; 50% -64%, serious; and 70% -100%, complete. These variables will be measured in the pre-evaluation, first evaluation (week 1), second evaluation (Week 4, short term) and third evaluation (Week 12, medium term).;Visual Analog Scale (VAS) for pain. The subjects participating in the study indicated the intensity of their pain by means of the EVA of 100mm, they had to signal in a horizontal line of 100mm where they would place their pain, being 0mm "no pain" and the 100mm would be "the worst pain imaginable". These variables will be measured in the pre-evaluation, first evaluation (week 1), second evaluation (Week 4, short term) and third evaluation (Week 12, medium term).;General Stability Index (OBI). We obtained this measurement through a dynamic stabilometric platform (Balance System ™ SD, Biodex, New York-USA). The General Stability Test was applied in level of difficulty 4, with 1 being the highest and 8 the least difficulty. The platform is free in the anterior-posterior and medial-lateral axes, it allows obtaining the OBI through the deviations with respect to a zero point established before the test, with the platform stable. Two 20-second tests were performed, with one minute between each test, with the score of the second test that was chosen for the statistical analysis. These variables will be measured in the pre-evaluation, first evaluation (week 1), second evaluation (Week 4, short

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Spain

Contacts

Public ContactCarlos Utrera

Universidad de Sevilla

cbernal495@gmail.com+34627382889

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 26, 2026